Merck & Co., Inc. (NYSE:MRK)

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

How Health Care Stocks Responded to the Shelved Health Care Bill

Despite touting himself as an incredible dealmaker and negotiater, Trump faced the biggest defeat of his presidency thus far when legislation to repeal the Affordable Care Act was pulled from ...
Read Full Story »

DuPont, Chevron Take DJIA Down Thursday

March 16, 2017: Markets opened higher again Thursday but the uptick did not last longer. Within an hour shares had dropped and a brief turn higher was foiled quickly. The ...
Read Full Story »

Intel, GE Weigh on DJIA Monday

March 13, 2017: Markets opened higher Monday maybe as a result of this morning's announcement that Intel is ponying up $15.3 billion for autonomous driving firm Mobileye. Trading has not ...
Read Full Story »

Short Sellers Back Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Chevron, Verizon Sink DJIA on Tuesday

March 7, 2017: Markets opened slightly lower again Tuesday seem to be pausing to consider the impact of the replacement healthcare bill the Republicans introduced in the House on Monday. There's ...
Read Full Story »
FDA_logo

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) each saw their shares sink early on Monday after they gave an update on their type 2 diabetes treatment. ...
Read Full Story »
Prescription drugs

Why Short Sellers Are Making a Massive Bet in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
tired frustrated unhappy business person

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Merck & Co. (NYSE: MRK) saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease. ...
Read Full Story »
thinkstockphotos-522646895

Apple, JPMorgan Dominate DJIA on Tuesday

February 14, 2017: Markets opened mixed Tuesday as investors and traders stepped back a bit from the pace of the last few days' trading. Although the three major indexes traded ...
Read Full Story »
Pair of dice

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Medical vaccine in shoulder, vaccination

Why Merck’s Q4 Earnings Aren’t Enough for Investors

Merck & Co. (NYSE: MRK) reported its fourth-quarter financial results before the markets opened on Thursday. The company posted $0.89 in earnings per share (EPS) and $10.12 billion in revenue, ...
Read Full Story »
Dow

The Top 2 Dow Stocks Reporting on Thursday

24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck & Co. Inc. (NYSE: MRK) and Visa Inc. (NYSE: ...
Read Full Story »
Profit or Loss

What to Expect From Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week. Five of the Dow stocks are reporting next ...
Read Full Story »